Literature DB >> 10210640

Splenic immune suppression in sepsis: A role for IL-10-induced changes in P38 MAPK signaling.

G Y Song1, C S Chung, M G Schwacha, D Jarrar, I H Chaudry, A Ayala.   

Abstract

BACKGROUND: Studies have indicated that following the induction of sepsis, there is a late (24 h) generalized suppression of the immune response which is associated with increased anti-inflammatory mediator release (e.g., IL-10). However, the mechanisms by which this occurs are unknown. In this regard, recent studies indicate that p38 mitogen-activated protein kinase (p38 MAPK) may play a central role in transducing the signals from immunosuppressive agents which in turn may alter lymphoid cytokine release. The aim of this study, therefore, was to determine whether the anti-inflammatory mediator IL-10 alters splenocyte IL-2 and IFN-gamma release, as well as the expression and activation of p38 MAPK in septic animals.
MATERIALS AND METHODS: Splenocytes (SPL) (or for some experiments purified T cells) were harvested from mice subjected 24 h earlier to either sepsis by cecal ligation and puncture (CLP) or Sham-CLP and stimulated with 2.5 microg concanavalin A (ConA)/ml in the presence or absence of either monoclonal antibody (Mab) to IL-10 (4 microg/ml) or IgG control. In subsequent studies, sepsis was induced in C57BL/6J and C57BL/6 IL-10 knockout mice, and SPL harvested and stimulated with ConA. SPL cytokine release was measured by ELISA, and the expression and phosphorylation of p38 MAPK were measured by Western analysis.
RESULTS: The results indicate that Th1 cytokine (IL-2, IFN-gamma) release was depressed by sepsis, while p38 MAPK expression and activity were increased in SPL as well as in T-cells. Neutralization of IL-10 by in vitro use of anti-IL-10 Mab and in the IL-10 knockout animal restored the Th1 response and caused a downregulation of p38 MAPK expression and activity after CLP. Thus, IL-10 appears to contribute to the increase in p38 MAPK activity and expression and the corresponding suppression of Th1 response seen in late sepsis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210640     DOI: 10.1006/jsre.1998.5556

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  12 in total

Review 1.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

2.  Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice.

Authors:  Yanli Ding; Chun-Shiang Chung; Sarah Newton; Yaping Chen; Stacey Carlton; Jorge E Albina; Alfred Ayala
Journal:  Shock       Date:  2004-08       Impact factor: 3.454

3.  Change of TH1/TH2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection.

Authors:  Yong-hao Yu; Nai-qiang Cui; Qiang Fu; Jun Li
Journal:  Chin J Integr Med       Date:  2005-06       Impact factor: 1.978

4.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

5.  Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.

Authors:  Robert A Finkelstein; Yongqing Li; Baoling Liu; Fahad Shuja; Eugene Fukudome; George C Velmahos; Marc deMoya; Hasan B Alam
Journal:  J Surg Res       Date:  2010-05-10       Impact factor: 2.192

Review 6.  Role of cytokines as a double-edged sword in sepsis.

Authors:  Hina Chaudhry; Juhua Zhou; Yin Zhong; Mir Mustafa Ali; Franklin McGuire; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  In Vivo       Date:  2013 Nov-Dec       Impact factor: 2.155

Review 7.  Regulation of chemokine expression by antiinflammatory cytokines.

Authors:  Thomas A Hamilton; Yoshihiro Ohmori; Julie Tebo
Journal:  Immunol Res       Date:  2002       Impact factor: 4.505

8.  IL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2.

Authors:  Swati Patel; Shamal Vetale; Pradeep Teli; Rajesh Mistry; Shubhada Chiplunkar
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

9.  CD28 Agonism Improves Survival in Immunologically Experienced Septic Mice via IL-10 Released by Foxp3+ Regulatory T Cells.

Authors:  Yini Sun; Jianfeng Xie; Jerome C Anyalebechi; Ching-Wen Chen; He Sun; Ming Xue; Zhe Liang; Kristen N Morrow; Craig M Coopersmith; Mandy L Ford
Journal:  J Immunol       Date:  2020-11-06       Impact factor: 5.422

Review 10.  Bench-to-bedside review: latest results in hemorrhagic shock.

Authors:  Martin K Angele; Christian P Schneider; Irshad H Chaudry
Journal:  Crit Care       Date:  2008-07-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.